| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.26 | 0.04 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |